Home / Companies / VRTX / Catalysts / Page 2 Catalysts · VRTX · CIK 875320 · page 2 of 2 VRTX catalysts and FDA events, page 2. Updated November 16, 2026 Snapshot 20261116T222116Z Built 2026-11-16 22:21 UTC
The next PDUFA date, the soonest catalysts with their source quotes and the latest FDA decisions are on VRTX PDUFA dates and upcoming catalysts . This page continues the list.
Past catalysts and FDA decisions (continued) Date Drug Company Event Indication Status Source December 20, 2024 vanzacaftor VRTX FDA approval people with CF 6 years of age and older Approved SEC Form 8-K December 13, 2024 Orkambi (ivacaftor; lumacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA October 31, 2023 exagamglogene autotemcel (CTX001) VRTX Advisory committee — Completed FDA advisory committee calendar May 3, 2023 Kalydeco (ivacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA April 26, 2023 Trikafta (Copackaged) (elexacaftor, ivacaftor, tezacaftor; ivacaftor) VRTX FDA approval — Approved openFDA Drugs@FDA September 2, 2022 Orkambi (ivacaftor; lumacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA June 8, 2021 Trikafta (Copackaged) (elexacaftor, ivacaftor, tezacaftor; ivacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA December 21, 2020 Kalydeco (ivacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA December 21, 2020 Symdeko (Copackaged) (ivacaftor; ivacaftor, tezacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA December 21, 2020 Trikafta (Copackaged) (elexacaftor, ivacaftor, tezacaftor; ivacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA September 24, 2020 Kalydeco (ivacaftor) VRTX Label expansion — Approved openFDA Drugs@FDA October 21, 2019 Trikafta (Copackaged) (elexacaftor, ivacaftor, tezacaftor; ivacaftor) VRTX FDA approval — Approved openFDA Drugs@FDA August 7, 2018 Orkambi (ivacaftor; lumacaftor) VRTX FDA approval — Approved openFDA Drugs@FDA February 12, 2018 Symdeko (Copackaged) (ivacaftor; ivacaftor, tezacaftor) VRTX FDA approval — Approved openFDA Drugs@FDA
FDA calendar PDUFA dates PDUFA calendar AdCom calendar FDA approvals today CRL tracker PDUFA outcomes dataset Indications Every catalyst is quoted from VRTX’s SEC filings, FDA records or ClinicalTrials.gov; each row links its primary source. Dates move; the linked filing is authoritative. Not investment advice.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.